D'Orazi, Gabriella
 Distribuzione geografica
Continente #
AS - Asia 1.468
NA - Nord America 765
SA - Sud America 650
EU - Europa 218
AF - Africa 53
OC - Oceania 1
Totale 3.155
Nazione #
US - Stati Uniti d'America 684
SG - Singapore 668
BR - Brasile 563
CN - Cina 313
VN - Vietnam 161
HK - Hong Kong 135
IT - Italia 107
MX - Messico 53
AR - Argentina 40
BD - Bangladesh 34
IN - India 33
GB - Regno Unito 27
FR - Francia 24
IQ - Iraq 23
ZA - Sudafrica 18
ID - Indonesia 17
SA - Arabia Saudita 15
UA - Ucraina 14
EC - Ecuador 12
RU - Federazione Russa 10
UZ - Uzbekistan 10
CO - Colombia 9
PK - Pakistan 9
CA - Canada 8
KE - Kenya 8
MA - Marocco 8
DE - Germania 6
JO - Giordania 6
NL - Olanda 6
NP - Nepal 6
UY - Uruguay 6
KZ - Kazakistan 5
PY - Paraguay 5
TN - Tunisia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BO - Bolivia 4
HN - Honduras 4
IL - Israele 4
PE - Perù 4
TR - Turchia 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
EG - Egitto 3
ES - Italia 3
PT - Portogallo 3
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
JM - Giamaica 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
RE - Reunion 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
GF - Guiana Francese 1
HU - Ungheria 1
IE - Irlanda 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
YE - Yemen 1
Totale 3.155
Città #
San Jose 352
Singapore 346
Ashburn 178
Beijing 155
Hong Kong 133
Rome 73
Ho Chi Minh City 68
São Paulo 40
Mexico City 39
Hanoi 33
Rio de Janeiro 18
Belo Horizonte 16
Curitiba 13
Baghdad 10
Campinas 10
Tashkent 9
Dhaka 8
Santa Clara 8
Brasília 7
Amman 6
Jeddah 6
Biên Hòa 5
Casablanca 5
Goiânia 5
Haiphong 5
Montevideo 5
Nairobi 5
Osasco 5
Porto Alegre 5
Quito 5
Recife 5
Riyadh 5
Salvador 5
Diadema 4
Erbil 4
Fortaleza 4
Frankfurt am Main 4
Guarulhos 4
Jequié 4
Kathmandu 4
Lima 4
Piracicaba 4
Quimilí 4
Ribeirão das Neves 4
Santa Cruz 4
Sorocaba 4
Thái Bình 4
Volta Redonda 4
Baku 3
Boa Vista 3
Bogotá 3
Buenos Aires 3
Bình Dương 3
Bắc Giang 3
Canoas 3
Caxias do Sul 3
Dammam 3
Dubai 3
Durban 3
Feira de Santana 3
Florianópolis 3
Governador Valadares 3
Johannesburg 3
Joinville 3
Kyiv 3
La Plata 3
Lahore 3
London 3
Manaus 3
Maricá 3
Marília 3
Mauá 3
Newark 3
Ninh Bình 3
Pirapora 3
Pretoria 3
Quảng Ngãi 3
Quận Bình Thạnh 3
São Gonçalo 3
São José 3
Thái Nguyên 3
Viamão 3
Addis Ababa 2
Ahmedabad 2
Aktobe 2
Alvorada 2
Amsterdam 2
Angra dos Reis 2
Ankara 2
Aparecida de Goiânia 2
Araguaína 2
Araraquara 2
Araucária 2
Araxá 2
Armenia 2
Arraial do Cabo 2
Asunción 2
Atlanta 2
Barbacena 2
Barra da Estiva 2
Totale 1.786
Nome #
KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression 30
HIPK2 as a Novel Regulator of Fibrosis 30
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 27
Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies 27
N6-Methyldeoxyadenosine, a nucleoside commonly found in prokaryotes, induces C2C12 myogenic differentiation 26
Zn(II)-curc targets p53 in thyroid cancer cells 26
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases 25
ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress 24
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status 24
ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression 23
P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex 23
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 23
Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function 22
Clearing mutant p53 with natural compounds: implication for anticancer therapeutical approaches 22
Targeting hypoxia in tumor: a new promising therapeutic strategy 22
Aspetti ultrastrutturali ed immunochimici della componente vasale del timo in condizioni normali e patologiche 22
Targeting mutant p53 in cancer: the latest insights 22
Azurin modulates the association of Mdm2 with p53: SPR evidence from interaction of the full-length proteins 22
Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways 21
NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells 21
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage 21
SAHA/5-AZA Enhances Acetylation and Degradation of mutp53, Upregulates p21 and Downregulates c-Myc and BRCA-1 in Pancreatic Cancer Cells 21
P53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions 21
VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor 21
Use of zinc in combination with chemotherapy for treating cancer 21
Establishment and characterization of a human continuous cell line from a IVs neuroblastoma 21
Ultrastructurale evidence of the mechanism responsible for Interleukin-4 activated rejection of a spontaneous murine adenocarcinoma 20
Sintesi di laminina da parte delle cellule NK e dei linfociti T di ratto 20
Pyrazolone-Based Zn(II) Complexes Display Antitumor Effects in Mutant p53-Carrying Cancer Cells 20
Hypoxia-inducible factor -1 (HIF-1) antagonizes p53-mediated apoptosis 20
Hyperglycemia triggers HIPK2 protein degradation 20
Aspetti ultastrutturali di lingua e paradenzio di ratti alimentati con dieta aproteica 20
Ewing's sarcoma lines synthesize laminin and fibronectin 20
Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53 20
Analysis of type V collagen as a component of breast carcinoma desmoplastic stroma 20
Activation of p53-dependent apoptosis in HIPK2 depleted tumor cells: an approach of combination therapy with drug, zinc, and deacetylase inhibitors 20
Interplay between endoplasmic reticulum (ER) stress and autophagy induces mutant p53H273 degradation 20
Zinco come adiuvante nelle chemioterapie per la riattivazione del pathway oncosoppressorio HIPK2/p53 20
HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA 19
p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK 19
Expression and synthesis of fibronectin and laminin by an intestinal epithelial cell line 19
Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice 19
Mutant P53, stabilized by its interplay with HSP90, activates a positive feed-back loop between NRF2 and P62 that induces chemo-resistance to apigenin in pancreatic cancer cells 19
Aspetti differenziativi in una coltura di cellule dell'epitelio intestinale e sintesi di matrice extracellulare 19
HIPK2 downregulates vimentin and inhibits breast cancer cell invasion 19
Analysis of MMP-2 and MMP-9 activity in prostate fluids, tissue homogenates and primary cell culture from patients with prostate cancer or benign prostate disease 19
The Role of Autophagy in Brain Tumors 18
Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells 18
HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations 18
HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets 18
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies 18
Cisti odontogene dei mascellari: aspetti ultrastrutturali dello stroma 18
Zinc supplementation counteracts cobalt-induced inhibition of homeodomain-interacting protein kinase-2 (HIPK2) and restores tumor chemosensitivity and p53 apoptotic function 18
Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis 18
The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions 18
Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53 18
Expression and synthesis of fibronectin (FN) by rat NK cells: Possible involvement in the NK-target interaction 18
Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity 18
Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo 17
Tumor cell response to cisplatin requires HIPK2 and p53 phosphorylation at ser46 17
Autophagy manipulation as a strategy for efficient anticancer therapies: Possible consequences 17
MDM2 transcriptional and posttranscriptional regulation by the HIPK2/p53 complex: a novel pathway for regulating p53 apoptotic function 17
Immunohystochemical distribution of type IV gelatinase A and type V collagen in ductal invasive carcinoma 17
Wt-p53 interferes with the v-Ha-ras pathway by inactivating ERK2/MAPK 17
A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells 17
Exogenous wt-p53 is stable and transcriptionally active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting 17
Exogenous wt-p53 protein is transcriptionally active in v-Ha-ras transformed C2C12 cells, but not in their non-transformed counterparts: a model for tumour gene therapy 17
Combination therapy strategies in HIPK2 knockdown tumor cells require Sirt1 inhibitor to activate p53 apoptotic transcription 17
Mutant p53 and cellular stress pathways: A criminal alliance that promotes cancer progression 17
Laminin increase and localization during neural differentiation of a human neuroblastoma cell line 17
Updates on HIPK2: a resourceful oncosuppressor for clearing cancer 17
Zinc supplementation to chemotherapy of tumor cells restores p53 and HIPK2 activities, chemosensitivity and reduces tumor growth 17
Type IV collagenase activity promotes endothelial cell formation into capillary-like structures on basement membrane in vitro 17
HIPK2 contributes to PCAF-mediated acetylation of p53 after non-apoptotic DNA damage 17
Blockade of HIPK2 apoptotic function is involved in chemoresistance to cisplatin in ovarian cancer cells 17
NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells 17
Synthesis of laminin and fibronectin by Ewing's sarcoma lines 17
Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line 16
Il trasferimento genico di p53 induce iper-sensibilita‚ alle basse dosi di raggi X in cellule di glioblastoma: una nuova strategia per convertire il fenotipo radio-resistente in radio-sensibile 16
ERK2/MAPK, a new target for p53 in the cell cycle arrest 16
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions 16
HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition 16
Morphologic study of the vasal component of human thymus and thimoma 16
Novel approaches to target the p53 and hypoxia pathways for cancer therapy 16
Interplay between hypoxia and HIPK2/p53 signaling in tumor cells: molecular mechanisms and therapeutical implications 16
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death 16
p53 Function and Dysfunction in Human Health and Diseases 16
Zinc antagonizes HIF-1/VEGF signaling in vitro and in vivo 16
Zinc Supplementation Enhances the Pro-Death Function of UPR in Lymphoma Cells Exposed to Radiation 16
Sep corticali e midollari nel ratto dopo trauma spinale 16
Cytogenetic, molecular, immunologic, and ultrastructural study on an established cell line of a stage III neuroblastoma 16
PGE2 Released by Pancreatic Cancer Cells Undergoing ER Stress Transfers the Stress to DCs Impairing Their Immune Function 16
NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study 16
The non-metastatic nature of pleural malignant mesothelioma cells is associated with low levels of 72kDa type IV gelatinase A 16
A novel Zn(II)-compound reactivates mutant p53 protein in cancer cells: molecular mechanisms and therapeutical implications 16
Misfolded p53 conformation in Alzheimer cells depends on deregulated HIPK2 that can be counteracted by zinc 16
Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis 16
Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells 15
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis 15
Gentian violet induces wtp53 transactivation in cancer cells 15
Totale 1.904
Categoria #
all - tutte 16.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.311 0 0 0 24 51 21 91 74 267 46 345 392
2025/20262.086 266 36 352 351 434 262 385 0 0 0 0 0
Totale 3.397